Spinal cord injury (SCI) causes permanent dysfunction in the body movement and sensation. It is well known that recovery becomes more difficult as time passes from injury. Even with the power of stem cell transplant, it is still hard to cure the late phase of SCI. Despite the difficulty, majority of patients suffering from SCI are clinically late phase. Thus, overcoming the late phase of SCI is an important mission. CPTX is the structurally guided synthetic peptide that joins the pre-synaptic neurexin and the post-synaptic AMPA receptors (Suzuki, Sasakura et al., Science, (2020)). We previousl
ePoster · Neuroscience